Chemical Structure (Azasite 01)
Azasite Solution/ Drops
Product Images NDC 82584-307
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Azasite (NDC 82584-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Thea Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure A (Azasite 02)
Figure B (Azasite 03)
Figure C (Azasite 04)
Figure D (Azasite 05)
Figure E (Azasite 06)
Figure F (Azasite 07)
Principal Display Panel (2.5 mL Bottle Carton)
AzaSITE is a medication for ophthalmic use only. Each ml contains Rathromycin (10mg) and inactive ingredients such as Mannitol, Sodium Chloride Edette Disodum, and Water for Injcton. Berzabonium Chorde (0.03 g) is the preservative used in the medication. The recommended dosage is to instill 1-2 drops in the affected eye(s) once daily for five days. AzaSITE should be stored at 2° to 8% 36" to 46" but should not be used if the neckband is not intact. This medication is manufactured in the U.S. by Thea Pharma Inc. and is a registered trademark of Sun Pharma. For more information, refer to the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
